glp-1 or metformin Analogs and DeFronzo's Octet What Next When Metformin Isn't
Description
Normally, doctors start you on a low dose and gradually increase it to curb gastrointestinal side effects
Included in the propensity matching were medications and conditions that could introduce confounding bias such as obstructive sleep apnea, mood disorders, anxiety disorders, chronic pain syndromes, benzodiazepines, and antihistamines

The full search strategy is detailed in Supplementary Table S1

However, current evidence points to at least partial mediation through central mechanisms as direct activation of central GIPRs can suppress food intake and decrease body weight, whereas deletion of these receptors blunts such effects and protects against obesity by altering feeding behavior (NamKoong et al., 2017

The amplitude of such effects of GLP-1 signaling may be sex-dependent as, in a food choice task based on flavor, women were more likely than men to change their flavor preferences after a GLP-1 iv infusion [131]

For someone weighing 250 lbs, that is roughly 715 additional pounds
